Cours suspendu

Autres langues Centessa Pharmaceuticals plc

Actions

CNTA

US1523091007

Recherche biotechnologique et médicale

Temps Différé Nasdaq 22:00:00 23/06/2026			Varia. 5j.	Varia. 1 janv.
40,50 ^USD	+0,80%		-.--%	+61,94%

24/06	Le Swiss Market Index prolonge son rally; l'action OC Oerlikon progresse	MT
24/06	Eli Lilly finalise l’acquisition de Centessa Pharmaceuticals	MT

Autres langues

24/06	Swiss Market Index Extends Rally; OC Oerlikon Shares Gain
24/06	Eli Lilly Completes Acquisition of Centessa Pharmaceuticals
24/06	Centessa Pharmaceuticals plc(NasdaqGM:CNTA) dropped from NASDAQ Composite Index
24/06	Centessa Pharmaceuticals plc(NasdaqGS:CNTA) dropped from NASDAQ Biotechnology Index
24/06	Eli Lilly and Company completed the acquisition of Centessa Pharmaceuticals plc from Medicxi Ventures (UK) LLP, Index Ventures SA, General Atlantic Service Company, L.P. and other shareholders.
22/06	UK High Court Approves Lilly's $7.8 Billion Acquisition of Centessa
22/06	Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales
22/06	Centessa Pharmaceuticals plc(NasdaqGS:CNTA) dropped from S&P Global BMI Index
26/05	Eli Lilly to Acquire Three Vaccine Developers for Up to $3.83 Billion
20/05	Eli Lilly Buys Engage Biologics for Up to $202 Million
11/05	Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA
06/05	Eli Lilly Plans to Sell About $8 Billion of Bonds to Fund Acquisitions
06/05	Eli Lilly Plans to Sell About $8 Billion of Bonds to Fund Acquisitions
05/05	Centessa Pharmaceuticals plc Reports Earnings Results for the First Quarter Ended March 31, 2026
27/04	Eli Lilly to Buy Ajax Therapeutics for Up to $2.3 Billion -- Update
20/04	Eli Lilly to Strengthen Cancer Treatment Portfolio With $7 Billion Deal for Kelonia
20/04	Eli Lilly to Buy Kelonia Therapeutics for Initial $3.25 Billion -- Update
07/04	Gilead Sciences to Buy Clinical-Stage Biotech Tubulis for Up to $5 Billion -- Update
01/04	Nxera Partner Centessa to Be Acquired by Lilly, Retains Royalty Rights
01/04	Morning Meeting: Ahora el petróleo es vuestro problema
01/04	Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA
31/03	Centessa Pharmaceuticals plc Reports Earnings Results for the Full Year Ended December 31, 2025
31/03	Top Midday Gainers
31/03	Eli Lilly to Acquire Centessa Pharmaceuticals in Deal Valued at Up to $7.8 Billion; Shares Rise
31/03	Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders?